ATRA vs QCOM · rev $128.9M vs P/E 16, rev $44.28B
Atara Biotherapeutics Inc (ATRA) versus Qualcomm Incorporated (QCOM) — a side-by-side from cached financials, not a winner call.
Atara Biotherapeutics Inc (ATRA) is a biotechnology company listed on NASDAQ.
Qualcomm Incorporated (QCOM) is a semiconductors company listed on US. It is led by Cristiano Amon.
Latest reported ATRA revenue for 2024-12-31 was $128.9M. Net income was -$85.4M. Revenue was up 1404.0% from 2023-12-31 to 2024-12-31. ATRA currently screens at market cap $87.1M.
Latest reported QCOM revenue for 2025-09-28 was $44.28B. Net income was $5.54B. QCOM currently screens at market cap $175.02B and trailing P/E 16.3.
ATRA currently screens at market cap $87.1M. QCOM currently screens at market cap $175.02B and trailing P/E 16.3.
Not investment advice. Open the ATRA and QCOM stock pages for the full models.
Not investment advice.